Harvard Apparatus Regenerative Technology, Inc. (HRGN) › Cash & EquivalentsHarvard Apparatus Regenerative Technology, Inc. (HRGN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $02011: $02012: $02013: $14.01M2014: $5.27M2015: $7.46M2016: $2.94M2017: $4.04M2022: $1.24M2023: $432.0K2024: $2.49M2025: $1.35M$1.35M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$1.35M-45.6%2024$2.49M+475.5%2023$432.0K-65.2%2022$1.24M—2017$4.04M+37.3%2016$2.94M-60.6%2015$7.46M+41.4%2014$5.27M-62.4%2013$14.01M—2012$0—2011$0—2009$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share